Cetilar® will be on the Crociati kits for a third consecutive year as confirmed today during the press conference held at the Stadio Tardini. The brand is also present in other high-profile sports such as motorsport, running, sailing and Paralympic sports. Through the Cetilar® brand, PharmaNutra S.p.A which was founded by the Lacorte brothers Andrea and Roberto in 2003, will once again be alongside the Parma Calcio 1913 players and staff in the top flight of Italian football.
“Back in April, our project was already to continue together on this extraordinary journey and we’re really happy that Parma Calcio shares this desire to continue and keep building on relationship that began with us as starting as the Medical Partner and then as Main Sponsor from the 2017-18,” said PharmaNutra S.p.A’s Managing Director Carlo Volpi at the press conference.
The agreement with Cetilar® with the Cetilar® cream among its range of projects goes beyond the classic sponsorship. The cream itself is ideal for reducing pain related to articulation or muscle injuries and it’s a partnership that operates on a 360-degree basis. There will be scientific cooperation with conferences on sports science and nutrition co-organised on a joint basis at the Stadio Tardini alongside the Club’s medical staff.
“To speak only about the Main Sponsorship would be reductive because with Parma Calcio, we’re constantly involved in a series of projects regarding science and marketing,” added Carlo Volpi. “We’re two ambitious organisations and we want to keep building something important together, something that allows the fans to dream and feel proud of our work.”
Parma Calcio 1913 CEO Luca Carra also spoke: “The agreement with Pharmanutra has been renewed. There is mutual trust that is always being consolidated further and we’re truly delighted to continue on our journey together. The Cetilar brand has been alongside us step-by-step since our rebirth and all the way up to our survival last season which was vital. It’s truly a pleasure to see how the collaboration between our organisations is continuing and growing in a way that allows us both to write new pages in our history. Obviously, we hope that this latest agreement can be a starting point for a season that proves to be very positive both for us and for PharmaNutra.”
Founded and leed by President Andrea Lacorte and Vice-President Roberto Lacorte, PharmaNutra was established in 2003 and produces innovative nutritional products, taking care of the entire production process. The effectiveness of the products produced is on show with 91 scientific publications and 6,000 subjects involved. The group produces and sells in Italy and abroad. In Italy, sale is through a 150-strong network and there are 33 selected partners abroad. PharmaNutra is a leader in the field of iron-based supplements through the SiderAL brand. Over the years, the company has developed a precise strategy by integrating all components, raw materials, intellectual property and scientific research.